, Hong Kong

Dragon Crown starts trading on the SEHK Main Board

Share price closes at HK$1.14 per share on the first day of listing, approximately 3.6% above the offer price.

Dragon Crown Group Holdings Limited (“Dragon Crown”), a leading integrated terminal service provider in the PRC specialising in the storage and handling of liquid chemical products, commenced trading on the Main Board of The Stock Exchange of Hong Kong on Friday.

Dragon Crown’s share price closed at HK$1.14 per share on Friday and reached an intra-day high of HK$1.16 per share, representing an increase of approximately 3.6% and 5.5% respectively compared to the offer price of HK$1.10 per share, according to a Dragon Crown report.

Mr Ng Wai Man, Chairman and Executive Director of Dragon Crown, said, “The listing of our shares today marks the beginning of a new chapter for Dragon Crown Group. The proceeds are to be used to expand our operation scale in the Nanjing Chemical Industry Park by establishing new jetty, storage tanks and other logistic infrastructure in order to capture more business opportunities. We intend to advance our business thereby bringing sustainable and fruitful returns to our shareholders.”

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Hong Kong Residency rule could boost office sector
The ultra-rich are also expected to set up family offices in the city.
Allegrow Biotech engineers technology to activate immune cells
The startup’s invention can be used to treat and potentially cure diseases like cancer.
Healthcare
Renminbi rise to fuel Bank of China HK’s growth
The lender expects the currency to be used more often in cross-border deals.
Retail Banking